Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Work In Process (2016 - 2026)

Standard Biotools has reported Work In Process over the past 15 years, most recently at $253000.0 for Q4 2025.

  • Quarterly Work In Process fell 42.89% to $253000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $253000.0 through Dec 2025, down 42.89% year-over-year, with the annual reading at $253000.0 for FY2025, 42.89% down from the prior year.
  • Work In Process was $253000.0 for Q4 2025 at Standard Biotools, down from $270000.0 in the prior quarter.
  • Over five years, Work In Process peaked at $28.9 million in Q1 2025 and troughed at $253000.0 in Q4 2025.
  • The 5-year median for Work In Process is $640000.0 (2024), against an average of $2.1 million.
  • The largest YoY upside for Work In Process was 4310.38% in 2025 against a maximum downside of 82.67% in 2025.
  • A 5-year view of Work In Process shows it stood at $867000.0 in 2021, then increased by 9.0% to $945000.0 in 2022, then tumbled by 53.12% to $443000.0 in 2023, then changed by 0.0% to $443000.0 in 2024, then plummeted by 42.89% to $253000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Work In Process are $253000.0 (Q4 2025), $270000.0 (Q3 2025), and $414000.0 (Q2 2025).